Key Finding
Electroacupuncture at 5/100 Hz significantly reduced neuropathic pain in rats by downregulating the CCL3/CCR5 chemokine axis and suppressing neuroinflammation in the spinal cord.
Chronic nerve pain, known as neuropathic pain, can be extremely difficult to treat with standard medications. Researchers in China investigated whether electroacupuncture—a form of acupuncture that uses mild electrical stimulation—could help relieve this type of pain and how it works in the body.
The study used rats with nerve injuries that cause chronic pain similar to what humans experience. The researchers applied electroacupuncture at specific frequencies (5 and 100 Hz, alternating) to acupuncture points for 30 minutes daily over one week, starting 8 days after the injury.
The results showed that electroacupuncture significantly reduced both sensitivity to touch and heat pain in the rats. By examining spinal cord tissue, the scientists discovered that electroacupuncture worked by reducing proteins called CCL3 and CCR5, which are involved in pain signaling. The treatment also decreased inflammation by lowering immune cells' activity and reducing inflammatory chemicals in the spinal cord.
What this means for patients: This study adds to growing evidence that electroacupuncture may be an effective option for managing chronic nerve pain, particularly when conventional medications haven't worked well. The research helps explain the biological mechanisms behind why electroacupuncture provides pain relief—it appears to reduce inflammation and interrupt pain signals in the nervous system. While this was an animal study, it supports the potential benefits of electroacupuncture for human neuropathic pain conditions. If you're considering acupuncture for chronic pain, consult with a licensed acupuncturist who has experience treating neuropathic pain conditions.
This study examined electroacupuncture's (EA) mechanism in alleviating neuropathic pain using a rat chronic constriction injury (CCI) model. EA at alternating 5/100 Hz frequencies was administered for 30 minutes daily over 7 days beginning on day 8 post-CCI. Outcomes were assessed via von Frey (mechanical allodynia) and Hargreaves tests (thermal hyperalgesia), with Western blotting, immunofluorescence, and ELISA analyses of spinal cord tissue.
Results demonstrated significant pain reduction with EA treatment. Mechanistically, EA downregulated CCL3/CCR5 axis expression in the spinal cord, proteins co-expressed by neurons and microglia. EA also suppressed glial cell activation and reduced proinflammatory cytokines (IL-1β, IL-6, TNF-α).
Clinical relevance: This study elucidates EA's analgesic mechanism through anti-neuroinflammatory pathways, specifically via chemokine signaling modulation. The 5/100 Hz alternating frequency protocol shows promise for neuropathic pain management, supporting EA as an evidence-based intervention when conventional pharmacotherapy proves inadequate. Further human trials are warranted to confirm translational applicability.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A 6-week integrative Korean medicine treatment centered on high-dose Angelica gigas produced clinically significant improvements in pain, function, and quality of life in a patient with 10-year treatment-refractory fibromyalgia unresponsive to opioid therapy.
📌 SSRIs significantly reduced pain and depression in fibromyalgia compared to placebo, but showed no significant advantage over non-pharmacological interventions including acupuncture for treating depression.
📌 Left-sided auricular vagus nerve stimulation reduced pro-inflammatory cytokines and increased anti-inflammatory markers and BDNF in women with fibromyalgia, despite not producing superior pain relief compared to sham treatment.